Estimates Revisions Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 6.340 USD | -7.04% |
|
-14.90% | -22.11% |
| 09-14 | Corbus Pharmaceuticals Holdings, Inc. - Special Call | |
| 09-14 | Corbus Pharma Reports Positive Top-Line Data From Weight-Loss Drug Study | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CRBP Stock
- Consensus Corbus Pharmaceuticals Holdings, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
